Gefarnate
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171942This classification denotes an antispasmotic agent with the molecular formula C27H44O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1ISE2Y6ULA, chemically known as 5,9,13-trimethyl-4,8,12-tetradecatrienoic acid 3,7-dimethyl-2,6-octadienyl ester but generally known as gefarnate, which bears US NIH Compound Identifier 5282182. European Medicines Agency schedules Gefarnate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07889MIG. The term GEFARNATE is an International Non-Proprietary Name. World Health Organization schedules gefarnate in its Anatomical Therapeutic Chemical (ATC) Classification. GEFARNATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gefarnate under HS 29161970 and SITC 51379. As of Q4 2014, GEFARNATE remains the US FDA Preferred Term for this commodity. Gefarnate bears US NLM identifiers UMLS ID C0017226 and NCI Concept Code C73187. SMILES: O(C(=O)CC/C=C(/CC/C=C(/CC/C=C(/C)C)C)C)C/C=C(/CC/C=C(/C)C)C.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.